Hamlet BioPharma invites to investor meeting on the 18th of June

Hamlet Biopharma
|
June 17, 2025

As previously announced Hamlet BioPharma invites you to our monthly investors’ meeting to be held on the 18th of June 2025, at 12:00.

Please click on the link below to participate in the meeting

https://us06web.zoom.us/j/85356339984?pwd=A7ljZREx4slaTJdwatjoa2jO7iMYTy.1

 

 

For further information, please contact

Catharina Svanborg, CEO, Hamlet BioPharma AB, +46 709 42 65 49,
catharina.svanborg@hamletpharma.com

Jakob Testad, CFO, Hamlet BioPharma AB, +46 708 48 42 10,
jakob.testad@hamletbiopharma.com

 

An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.
Hamlet BioPharma AB
Klinikgatan 32
SE-222 42 Lund
info@hamletbiopharma.com
Org. no. 556568-8958
Subscribe to receive
Pressreleases and Newsletters
© 2026
Hamlet BioPharma.